Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Pharmacoeconomics|February 26, 2018
Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology AppraisalIrina A Tikhonova, Tracey Jones-Hughes, James Dunham, et al.
BMC Cancer|April 25, 2015
A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patientsTristan Snowsill, Nicola Huxley, Martin Hoyle, et al.
Health Technology Assessment (Winchester, England)|September 23, 2014
A systematic review and economic evaluation of diagnostic strategies for Lynch syndromeTristan Snowsill, Nicola Huxley, Martin Hoyle, et al.
Age and Ageing|November 27, 2012
Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic modelChristopher Hyde, Jaime Peters, Mary Bond, et al.
Health Technology Assessment (Winchester, England)|July 7, 2017
The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluationNicola Huxley, Louise Crathorne, Jo Varley-Campbell, et al.
The Annals of Pharmacotherapy|January 14, 2023
Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer PerspectiveShiraz Halloush, Nimer S Alkhatib, Abdulaali R Almutairi, et al.
The Journal of Infectious Diseases|October 23, 2004
T helper cell type 2 responsiveness predicts future susceptibility to gastrointestinal nematodes in humansJoseph A Jackson, Joseph D Turner, Lawrence Rentoul, et al.
Health Technology Assessment (Winchester, England)|February 8, 2021
Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluationIrina A Tikhonova, Huiqin Yang, Segun Bello, et al.
Health Technology Assessment (Winchester, England)|February 25, 2016
The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic modelLouise Crathorne, Nicola Huxley, Marcela Haasova, et al.
Health Technology Assessment (Winchester, England)|September 14, 2018
Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysisRuben Mujica-Mota, Jo Varley-Campbell, Irina Tikhonova, et al.
Pageof 4